China Reform Health Management and Services Group Co., Ltd. (SHE:000503)
10.47
-0.01 (-0.10%)
Apr 24, 2025, 2:45 PM CST
SHE:000503 Revenue
China Reform Health Management and Services Group had revenue of 62.78M CNY in the quarter ending September 30, 2024, with 3.28% growth. This brings the company's revenue in the last twelve months to 369.39M, up 9.47% year-over-year. In the year 2023, China Reform Health Management and Services Group had annual revenue of 330.13M with 6.12% growth.
Revenue (ttm)
369.39M
Revenue Growth
+9.47%
P/S Ratio
27.76
Revenue / Employee
260.13K
Employees
1,420
Market Cap
10.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 330.13M | 19.05M | 6.12% |
Jan 1, 2023 | 311.08M | 58.56M | 23.19% |
Jan 1, 2022 | 252.52M | 45.14M | 21.77% |
Dec 31, 2020 | 207.37M | 77.46M | 59.62% |
Dec 31, 2019 | 129.91M | 34.43M | 36.06% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
Aier Eye Hospital Group | 20.62B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |